1401, 18e Rue
P-0143
Québec, Québec
Canada G1J 1Z4

Dernières nouvelles

Information non disponible

19 enregistrements « 1 de 2 »

Parnianpour P, Benatar M, Briemberg H, Dey A, Dionne A, Dupré N, Evans KC, Frayne R, Genge A, Graham SJ, Korngut L, McLaren DG, Seres P, Welsh RC, Wilman A, Zinman L, Kalra S

Mismatch between clinically defined classification of ALS stage and the burden of cerebral pathology

Article de revue

J Neurol, 271 (5), 2024.

Résumé | Liens:

GomezMancilla B, Meriggioli MN, Genge A, Roubenoff R, Espié P, Dupuy C, Hartmann N, Pezous N, Kinhikar A, Tichy M, Dionne A, Vissing J, Andersen H, Schoser B, Meisel A, Jordan B, Devlikamova F, Poverennova I, Stuchevskaya F, Lin TS, Rush JS, Gergely P

Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study

Article de revue

J Clin Neurosci, 119 , 2024.

Résumé | Liens:

Bouvier L, McKinlay S, Truong J, Genge A, Dupré N, Dionne A, Kalra S, Yunusova Y

Speech timing and monosyllabic diadochokinesis measures in the assessment of amyotrophic lateral sclerosis in Canadian French

Article de revue

Int J Speech Lang Pathol, 26 (2), 2024.

Résumé | Liens:

Kushol R, Luk CC, Dey A, Benatar M, Briemberg H, Dionne A, Dupré N, Frayne R, Genge A, Gibson S, Graham SJ, Korngut L, Seres P, Welsh RC, Wilman AH, Zinman L, Kalra S, Yang YH

SF2Former: Amyotrophic lateral sclerosis identification from multi-center MRI data using spatial and frequency fusion transformer

Article de revue

Comput Med Imaging Graph, 108 , 2023.

Résumé | Liens:

Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ,

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Article de revue

Lancet Neurol, 22 (5), 2023.

Résumé | Liens:

Picher-Martel V, Magnussen C, Blais M, Bubela T, Das S, Dionne A, Evans AC, Genge A, Greiner R, Iturria-Medina Y, Johnston W, Jones K, Kaneb H, Karamchandani J, Moradipoor S, Robertson J, Rogaeva E, Taylor DM, Vande Velde C, Yunusova Y, Zinman L, Kalra S, Dupré N

CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS

Article de revue

Amyotroph Lateral Scler Frontotemporal Degener, 24 (1-2), 2023.

Résumé | Liens:

Ishaque A, Ta D, Khan M, Zinman L, Korngut L, Genge A, Dionne A, Briemberg H, Luk C, Yang YH, Beaulieu C, Emery D, Eurich DT, Frayne R, Graham S, Wilman A, Dupré N, Kalra S

Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis

Article de revue

Hum Brain Mapp, 43 (5), 2022.

Résumé | Liens:

Salmon K, Anoja N, Breiner A, Chum M, Dionne A, Dupré N, Fiander A, Fok D, Ghavanini A, Gosselin S, Izenberg A, Johnston W, Kalra S, Matte G, Melanson M, O'Connell C, Ritsma B, Schellenberg K, Shoesmith C, Tremblay S, Williams H, Genge A

Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practices

Article de revue

Amyotroph Lateral Scler Frontotemporal Degener, 23 (3-4), 2022.

Résumé | Liens:

McMillan CT, Wuu J, Rascovsky K, Cosentino S, Grossman M, Elman L, Quinn C, Rosario L, Stark JH, Granit V, Briemberg H, Chenji S, Dionne A, Genge A, Johnston W, Korngut L, Shoesmith C, Zinman L, , Kalra S, Benatar M

Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches

Article de revue

Amyotroph Lateral Scler Frontotemporal Degener, 23 (7-8), 2022.

Résumé | Liens:

Bharti K, J Graham S, Benatar M, Briemberg H, Chenji S, Dupré N, Dionne A, Frayne R, Genge A, Korngut L, Luk C, Zinman L, Kalra S,

Functional alterations in large-scale resting-state networks of amyotrophic lateral sclerosis: A multi-site study across Canada and the United States

Article de revue

PLoS One, 17 (6), 2022.

Résumé | Liens:

19 enregistrements « 1 de 2 »
Signaler des ajouts ou des modifications

Projets actifs

  • Élaboration d'une base de données pour la clinique des maladies neuromusculaires du CHU de Québec , du 2022-04-01 au 2026-03-31
Information provenant du registre des projets de recherche de l'Université Laval